These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32602874)

  • 1. Health beneficial effects of resistant starch on diabetes and obesity via regulation of gut microbiota: a review.
    Liu H; Zhang M; Ma Q; Tian B; Nie C; Chen Z; Li J
    Food Funct; 2020 Jul; 11(7):5749-5767. PubMed ID: 32602874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms in the gut microbiota regulation and type 2 diabetes therapeutic activity of resistant starches.
    Li X; Chen R; Wen J; Ji R; Chen X; Cao Y; Yu Y; Zhao C
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133279. PubMed ID: 38906356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant starches and gut microbiota.
    Wen JJ; Li MZ; Hu JL; Tan HZ; Nie SP
    Food Chem; 2022 Sep; 387():132895. PubMed ID: 35413551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota.
    Tian S; Chu Q; Ma S; Ma H; Song H
    J Agric Food Chem; 2023 Oct; 71(41):14853-14869. PubMed ID: 37815013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved and variable responses of the gut microbiome to resistant starch type 2.
    Bendiks ZA; Knudsen KEB; Keenan MJ; Marco ML
    Nutr Res; 2020 May; 77():12-28. PubMed ID: 32251948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microbial amino acid metabolism in host metabolism.
    Neis EP; Dejong CH; Rensen SS
    Nutrients; 2015 Apr; 7(4):2930-46. PubMed ID: 25894657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis reveals gut microbiome and functional pathway alterations in response to resistant starch.
    Chen R; Zhang C; Xu F; Yu L; Tian F; Chen W; Zhai Q
    Food Funct; 2023 Jun; 14(11):5251-5263. PubMed ID: 37194392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enzymatically modified chestnut starch on the gut microbiome, microbial metabolome, and transcriptome of diet-induced obese mice.
    Lee ES; Song EJ; Nam YD; Nam TG; Kim HJ; Lee BH; Seo MJ; Seo DH
    Int J Biol Macromol; 2020 Feb; 145():235-243. PubMed ID: 31870873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New definition of resistant starch types from the gut microbiota perspectives - a review.
    Li C; Hu Y
    Crit Rev Food Sci Nutr; 2023; 63(23):6412-6422. PubMed ID: 35075962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connection between gut microbiome and the development of obesity.
    Zhi C; Huang J; Wang J; Cao H; Bai Y; Guo J; Su Z
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):1987-1998. PubMed ID: 31367997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenomic Insights into the Degradation of Resistant Starch by Human Gut Microbiota.
    Vital M; Howe A; Bergeron N; Krauss RM; Jansson JK; Tiedje JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30266729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
    Gomes JM; Costa JA; Alfenas RC
    Br J Nutr; 2015 Dec; 114(11):1756-65. PubMed ID: 26400630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Align resistant starch structures from plant-based foods with human gut microbiome for personalized health promotion.
    Li C; Hu Y
    Crit Rev Food Sci Nutr; 2023; 63(15):2509-2520. PubMed ID: 34515592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.